A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice.

Int J Nanomedicine · 2016 · PMC5167466 · PMID 28008250

Europe PMC DOI

hedged sentence

0.5100

closest p · 10.2× alpha

0.5100

boldest claim

The sentences

did not reach statistical significanceP =0.51not close (p > 0.1)

Although increase in absolute number of the subtype CD3 + /CD8 + T-cell in the PS-LY/CpG group did not reach statistical significance ( P =0.51), it was noticeable compared with that in the PBS group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.